Abstract
Liver transplantation (LT) today stands as the only effective and definitive treatment for end-stage liver failure. However, the ischemia-reperfusion (I/R) lesion, an always present kind of injury, is a major cause of primary dysfunction and is associated with the occurrence of acute and chronic rejection. In order to increase TH's success, methods have been developed to diminish I/R dama…